Title Host–microbial interactions in metabolic diseases: from diet to immunity
Author Ju-Hyung Lee and Joo-Hong Park*
Address School of Biological Sciences and Institute of Microbiology, Seoul National University, Seoul 08826, Republic of Korea
Bibliography Journal of Microbiology, 60(6),561-575, 2022,
DOI 10.1007/s12275-022-2087-y
Key Words microbiome, obesity, metabolic disease, lipid, inflammation
Abstract Growing evidence suggests that the gut microbiome is an important contributor to metabolic diseases. Alterations in microbial communities are associated with changes in lipid metabolism, glucose homeostasis, intestinal barrier functions, and chronic inflammation, all of which can lead to metabolic disorders. Therefore, the gut microbiome may represent a novel therapeutic target for obesity, type 2 diabetes, and nonalcoholic fatty liver disease. This review discusses how gut microbes and their products affect metabolic diseases and outlines potential treatment approaches via manipulation of the gut microbiome. Increasing our understanding of the interactions between the gut microbiome and host metabolism may help restore the healthy symbiotic relationship between them.